Risk stratification

Critical Pathways in Cardiology

Volumn 7, Issue 2, 2008, Pages 96-102

  Collins, Sean P ^a   Gheorghiade, Mihai ^a   Weintraub, Neal L ^a   Storrow, Alan B ^a   Pang, Peter S ^a   Abraham, William T ^a   Hiestand, Brian ^a   Fonarow, Gregg C ^a   Peacock, W Frank ^a  

^a Society of Chest Pain Centers   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CREATINE KINASE; CREATININE; GLUCOSE; HEMOGLOBIN; INFUSION FLUID; SODIUM; TROPONIN I;

ACUTE HEART FAILURE; ADVERSE OUTCOME; AGE; BARTHEL INDEX; BREATHING RATE; CARDIAC PATIENT; CARDIOVASCULAR RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EVALUATION; COMORBIDITY; CREATINE KINASE BLOOD LEVEL; CREATININE BLOOD LEVEL; DIURESIS; DYSPNEA; ECG ABNORMALITY; EDEMA; EMERGENCY CARE; GLUCOSE BLOOD LEVEL; HEALTH BEHAVIOR; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HEART RATE; HEART SIZE; HEMOGLOBIN BLOOD LEVEL; HIGH RISK PATIENT; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; HYPERTENSION; HYPONATREMIA; HYPOTENSION; HYPOXIA; KIDNEY DISEASE; LEUKOCYTE COUNT; LUNG EDEMA; MARRIAGE; MORTALITY; OXYGEN SATURATION; PATIENT MONITORING; PH; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; REVIEW; RISK ASSESSMENT; SEX ROLE; SODIUM BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; THORAX PAIN; TREATMENT RESPONSE; TRICUSPID VALVE DISEASE; UREA BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL;

EID: 67650168158     PISSN: 1535282X     EISSN: 15352811     Source Type: Journal    
DOI: 10.1097/HPC.0b013e318177dee4     Document Type: Review

References (68)

1. O'Connell JB, Bristow M. Economic impact of heart failure in the United States: a time for a different approach. J Heart Lung Transplant.1994;13: S107-S112.
2. Stevenson LW, Braunwald E. Recognition and management of patients with heart failure. In: Goldman L, Braunwald E, eds. Primary Cardiol ogy. Philadelphia: WB Saunders; 1998:310-329.
3. American Heart Association. Heart Disease and Stroke Statistics-2004 Update. Available at: heart/ 1079736729696HDSStats2004UpdateREV3-19-04.pdf. Accessed December 24, 2007.
4. Graff L, Orledge J, Radford MJ, et al. Correlation of the agency for health care policy and research congestive heart failure admission guideline with mortality: peer review organization voluntary hospital association initiative to decrease events (PROVIDE) for congestive heart failure. Ann Emerg Med. 1999;34:429-437.
5. Smith WR, Poses RM, McClish DK, et al. Prognostic judgments and triage decisions for patients with acute congestive heart failure. Chest. 2002;121:1610-1617.
6. Polanczyk CA, Rohde LE, Philbin EA, et al. A new casemix adjustment index for hospital mortality among patients with congestive heart failure. Med Care. 1998;36:1489-1499.
7. Adams KF Jr, Fonarow GC, Emerman CL, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2005;149:209-216.
8. Cleland JG, Swedberg K, Follath F, et al. The EuroHeart Failure survey programme-a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J. 2003;24:442-463.
9. Cuffe MS, Califf RM, Adams KF Jr, et al. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA. 2002;287:1541-1547.
10. Publication Committee for the VMAC Investigators. Intravenous nesirit- ide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. JAMA. 2002;287:1531-1540.
11. Rame JE, Sheffield MA, Dries DL, et al. Outcomes after emergency department discharge with a primary diagnosis of heart failure. Am Heart J. 2001;142:714-719.
12. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult-summary article a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to update the 2001 Guidelines for the Evaluation and an agement of Heart Failure). J Am Coll Cardiol. 2005;46:1116-1143.
13. Hunt SA, Baker DW, Chin MH, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. JHeart Lung Transplant. 2002;21:189-203.
14. Heart Failure Society of America. HFSA guidelines for the management of patients with heart failure due to left ventricular systolic dysfunction-pharmacological approaches. Congest Heart Fail. 2000;6:11-39.
15. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines ( Management of Heart Failure). Guidelines for the evaluation and management of heart failure. JAm Coll Cardiol. 1995;26:1376 -1398.Committee on Evaluation and Management of Heart Failure). Guidelines for the evaluation and management of heart failure. J Am Coll Cardiol. 1995;26:1376-1398.
16. Konstam M, Dracup K, Baker D. Clinical Practice Guidelines No 11: heart failure: evaluation and care ofpatients with left-ventricular systolic dysfunction. Provid Stud Res Note Agency Health Care Policy Res.1994;94.
17. Fonarow G, Abraham WT, Albert NM, et al. Characteristics, treatment and outcomes of patients hospitalized for heart failure with preserved systolic function: a report from OPTIMIZE-HF. J Am Coll Cardiol.2006;47(suppl A):47.
18. Selker HP, Griffith JL, D'Agostino RB. A time-insensitive predictive instrument for acute hospital mortality due to congestive heart failure: development, testing, and use for comparing hospitals: a multicenter study. Med Care. 1994;32:1040-1052.
19. Chin MH, Goldman L. Correlates of major complications or death in patients admitted to the hospital with congestive heart failure. Arch Intern Med. 1996;156:1814-1820.
20. Katz MH, Nicholson BW, Singer DE, et al. The triage decision in pulmonary edema. J Gen Intern Med. 1988;3:533-539.
21. Fonarow GC, Adams KF Jr, Abraham WT, et al.; for the ADHERE Scientific Advisory Committee, Study Group, and Investigators. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA. 2005;293:572-580.
22. Gheorghiade M, Abraham WT, Albert NM, et al.; for the OPTIMIZE- HF [Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure] Investigators and Coordinators. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA. 2006;296:2217-2226.
23. Gheorghiade M, Abraham WT, Albert NM, et al. Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry. Eur Heart J. 2007;28:980-988.
24. Filippatos G, Rossi J, Lloyd-Jones DM, et al. Prognostic value of blood urea nitrogen in patients hospitalized with worsening heart failure: insights from the Acute and Chronic Therapeutic Impact of a Vasopres- sin Antagonist in Chronic Heart Failure (ACTIV in CHF) study. JCardFail. 2007;13:360-364.
25. Formiga F, Chivite D, Manito N, et al. Predictors ofin-hospital mortality present at admission among patients hospitalised because of decompen- sated heart failure. Cardiology. 2007;108:73-78.
26. Diercks DB, Peacock WF, Kirk JD, et al. ED patients with heart failure: identification of an observational unit-appropriate cohort. Am J Emerg Med. 2006;24:319-324.
27. Auble TE, Hsieh M, Gardner W, et al. A prediction rule to identify low-risk patients with heart failure. Acad Emerg Med. 2005;12:514-521.
28. Bayes-Genis A, Lopez L, Zapico E, et al. NT-ProBNP reduction percentage during admission for acutely decompensated heart failure predicts long-term cardiovascular mortality. J Card Fail. 2005;11(suppl5):S3-S8.
29. Harrison A, Morrison LK, Krishnaswamy P, et al. B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea. Ann Emerg Med. 2002;39:131-138.
30. Cheng V, Kazanagra R, Garcia A, et al. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J Am Coll Cardiol. 2001;37:386-391.
31. Fonarow GC, Peacock WF, Phillips CO, et al. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompen- sated heart failure. J Am Coll Cardiol. 2007;49:1943-1950.
32. Januzzi JL, van Kimmenade R, Lainchbury J, et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP study. Eur Heart J. 2006;27:330 -337.
33. Yu CM, Sanderson JE. Plasma brain natriuretic peptide-an independent predictor of cardiovascular mortality in acute heart failure. Eur JHeart Fail. 1999;1:59-65.
34. Maisel A, Hollander JE, Guss D, et al. Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). Amulticenter study of B-type natriuretic peptide levels, emergency de-partment decision making, and outcomes in patients presenting with shortness of breath. J Am Coll Cardiol. 2004;44:1328-1333.
35. Kirk V, Bay M, Parner J, et al. N-terminal proBNP and mortality in hospitalised patients with heart failure and preserved vs. reduced systolic function: data from the prospective Copenhagen Hospital Heart Failure Study (CHHF). Eur J Heart Fail. 2004;6:335-341.
36. Januzzi JL Jr, Sakhuja R, O'Donoghue M, et al. Utility of aminoterminal pro-brain natriuretic peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department. Arch Intern Med. 2006;166:315-320.
37. Chen AA, Wood MJ, Krauser DG, et al. NT-proBNP levels, echo cardiographic findings, and outcomes in breathless patients: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) echocardiographic substudy. Eur Heart J. 2006;27:839-845.
38. Heart Failure Society of America. HFSA 2006 comprehensive heart failure practice guideline. JCard Fail. 2006;12:e1-e2.
39. Silvers SM, Howell JM, Kosowsky JM, et al. Clinical policy: critical issues in the evaluation and management of adult patients presenting to the emergency department with acute heart failure syndromes. Ann Emerg Med. 2007;49:627-669.
40. Peacock WF, Albert NM. Observation unit management of heart failure. EmergMed Clin North Am. 2001;19:209-232.
41. Peacock WF, Young J, Collins S, et al. Heart failure observation units: optimizing care. Ann Emerg Med. 2006;47:22-33.
42. Storrow AB, Collins SP, Lyons MS, et al. Emergency department observation of heart failure: preliminary analysis of safety and cost. Congest Heart Fail. 2005;11:68 -72.
43. Ivanov RI, Allen J, Sandham JD, et al. Pulmonary artery catheterization: a narrative and systematic critique of randomized controlled trials and recommendations for the future. New Horiz. 1997;5:268 -276.
44. Binanay C, Califf RM, Hasselblad V, et al. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA. 2005;294:1625-1633.
45. Brophy JM, Deslauriers G, Boucher B, et al. The hospital course and short term prognosis of patients presenting to the emergency room with decompensated congestive heart failure. Can J Cardiol. 1993;9:219-224.
46. Brophy JM, Deslauriers G, Rouleau JL. Long-term prognosis ofpatients presenting to the emergency room with decompensated congestive heart failure. Can J Cardiol. 1994;10:543-547.
47. Esdaile JM, Horwitz RI, Levinton C, et al. Response to initial therapy and new onset as predictors of prognosis in patients hospitalized with congestive heart failure. Clin Invest Med. 1992;15:122-131.
48. O'Neill JO, Bott-Silverman CE, McRae AT III, et al. B-type natriuretic peptide levels are not a surrogate marker for invasive hemodynamics during management of patients with severe heart failure. Am Heart J.2005;149:363-369.
49. Kazanegra R, Cheng V, Gaccia A, et al. A rapid test for B-type natriuretic peptide (BNP) correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study. J CardFail. 2001;7:21-29.
50. Wu AH. Serial testing of B-type natriuretic peptide and NTpro-BNP for monitoring therapy of heart failure: the role of biologic variation in the interpretation of results. Am Heart J. 2006;152:828-834.
51. Valle R, Prevaldi C, D'Eri A, et al. B-type natriuretic peptide predicts postdischarge prognosis in elderly patients admitted due to cardiogenic pulmonary edema. Am J Geriatr Cardiol. 2006;15:202-207.
52. Verdiani V, Nozzoli C, Bacci F, et al. Pre-discharge B-type natriuretic peptide predicts early recurrence of decompensated heart failure in patients admitted to a general medical unit. Eur J Heart Fail. 2005;7: 566-571.
53. Logeart D, Thabut G, Jourdain P, et al. Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. JAm Coll Cardiol. 2004;43:635-641.
54. Troughton RW, Frampton CM, Yandle TG, et al. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet. 2000;355:1126-1130.
55. Vinson JM, Rich MW, Sperry JC, et al. Early readmission of elderly patients with congestive heart failure. JAm GeriatrSoc. 1990;38:1290-1295.
56. Krumholz HM, Amatruda J, Smith GL, et al. Randomized trial of an education and support intervention to prevent readmission of patientswith heart failure. JAm Coll Cardiol. 2002;39:83-89.
57. Rich MW, Beckham V, Wittenberg C, et al. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl JMed. 1995;333:1190-1195.
58. Rohde LE, Goldraich L, Polanczyk CA, et al. A simple clinically based predictive rule for heart failure in-hospital mortality. J Card Fail. 2006;12:587-593.
59. Barsheshet A, Garty M, Grossman E, et al. Admission blood glucose level and mortality among hospitalized nondiabetic patients with heart failure. Arch Intern Med. 2006;166:1613-1619.
60. Burkhardt J, Peacock WF, Emerman CL. Predictors of emergency department observation unit outcomes. Acad Emerg Med. 2005;12:869-874.
61. Klein L, O'Connor CM, Leimberger JD, et al. Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study. Circulation. 2005;111:2454-2460.
62. Felker GM, Leimberger JD, Califf RM, et al. Risk stratification after hospitalization for decompensated heart failure. J Card Fail. 2004;10:460-466.
63. Lee DS, Austin PC, Rouleau JL, et al. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA. 2003;290:2581-2587.
64. Harjai KJ, Nunez E, Turgut T, et al. The independent effects of left ventricular ejection fraction on short-term outcomes and resource utilization following hospitalization for heart failure. Clinical Cardiol.1999;22: 184-190.
65. Butler J, Hanumanthu S, Chomsky D, Wilson JR. Frequency oflow-risk hospital admissions for heart failure. Am JCardiol. 1998;81:41-44.
66. Villacorta H, Rocha N, Cardoso R, et al. Hospital outcome and short term follow-up of elderly patients presenting to the emergency unit with congestive heart failure. Arq Bras Cardiol. 1998;70:167-171.
67. Chin MH, Goldman L. Correlates of major complications or death in patients admitted to the hospital with congestive heart failure. ArchIntern Med. 1996;156:1814-1820.
68. Plotnick GD, Kelemen MH, Garrett RB, et al. Acute cardiogenic pulmonary edema in the elderly: factors predicting in-hospital and one-year mortality. South Med J. 1982;75:565-569.